References
- Benveniste J, Henson P M, Cochrane C G. Leukocyte-dependent histamine release from rabbit platelets. J Exp Med 1972; 136: 1356–77
- Chignard M, Le Couedic J P, Tence M, Vargaftig B B, Benveniste J. The role of platelet-activating factor in platelet aggregation. Nature 1979; 279: 799–800
- Lee T, Lenihan D J, Malone B, Roddy L L, Wasserman S I. Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem 1984; 259: 5526–30
- Lotner G Z, Lynch J M, Betz S J, Henson P M. Human neutrophil-derived platelet activating factor. J Immunol 1980; 124: 676–84
- Arnoux B, Duval D, Benveniste J. Release of platelet-activating factor (PAF-acether) from alveolar macrophages by the calcium ionophore A23187 and phagocytosis. Eur J Clin Invest 1980; 10: 437–41
- Schleimer R P, Macglashan D W, Jr, Peters S P, Pinckard R N, Adkinson N F, Jr, Lichtenstein L M. Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis 1986; 133: 614–7
- Camussi G, Aglietta M, Malavasi F, et al. The release of platelet-activating factor from human endothelial cells in culture. J Immunol 1983; 131: 2397–403
- Findlay S R, Lichtenstein L M, Hanahan D J, Pinckard R N. Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine. Am J Physiol 1981; 241: 130–3
- Humphrey D M, McManus L M, Hanahan D J, Pinckard R N. Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. Lab Invest 1984; 50: 16–25
- Hahn H L, Purnama I, Lang M, Sannwald U, Stenzel H. Effects of platelet activating factor on release of mucus from tracheal submucosal glands in the ferret. Am Rev Respir Dis 1985; 131: A27
- Wardlaw A J, Moqbel R, Cromwell O, Kay A B. Platelet-activating factor a potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986; 78: 1701–6
- Shaw J O, Pinckard R N, Ferrigni K S, McManus L M, Hanahan D J. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor). J Immunol 1981; 127: 1250–5
- Yasaka T, Boxer L A, Baehner R L. Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF). J Immunol 1982; 128: 1939–44
- Kloprogge E, de Haas G H, Gorter G, Akkerman J WN. Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. Thromb Res 1983; 29: 595–608
- Cockcroft D W. Mechanism of perennial allergic asthma. Lancet 1983; ii: 253–5
- Okuda M, Ohtsuka H, Sakaguchi K, Watase T. Nasal histamine sensitivity in allergic rhinitis. Ann Allergy 1983; 51: 51–5
- Hisamatsu K. A study on histamine and histaminase activity in nasal allergy. J Otolaryngol Jpn 1975; 78: 16–34
- Barnes P J, Cuss F M, Palmer J B. The effect of airway epithelium on smooth muscle contractility in bovine trachea. Br J Pharmac 1985; 86: 685–91
- Barnes P J. Asthma as an axon reflex. Lancet 1986; i: 242–4
- Dulfano M J, Luk C K, Beckage M, Wooten O. Ciliary inhibitory effects of asthma patients' sputum. Clin Sci 1982; 63: 393–6
- McManus L M, Hanahan D J, Pinckard R N. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine. J Clin Invest 1981; 67: 903–6
- Sigal C E, Valone F H, Holtzman M J, Goetzl E J. Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-O-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC). J Clin Immunol 1987; 7: 179–84
- Bussolino F, Camussi G, Aglietta M, et al. Human endothelial cells are target for platelet-activating factor. J Immunol 1987; 139: 2439–46
- Miadonna A, Tedeschi A, Arnoux B, Sala A, Zanussi C, Benveniste J. Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways. Am Rev Respir Dis 1989; 140: 142–7